Last March, a software engineer named David in Austin told me he'd been running Semax every morning for six weeks and felt sharper at work but couldn't shut his brain off at night. His prescriber added Selank in the late afternoon. "Within three days the evening anxiety dropped by maybe 70 percent," he said, "and the daytime focus stayed exactly the same." He paused. "It's weird that two peptides that look so similar on paper can feel like opposite drugs."
That experience captures the central question people land on when they search "semax vs selank." Both peptides were born in the same lab, both are seven amino acids long, both share a stabilizing tail, and both go up your nose. But they do very different things once they get to the brain. Here's the thing: the differences are structural, not just marketing copy, and they trace back to the completely unrelated parent molecules each peptide was carved from.
This is an informational comparison, not a substitute for prescriber guidance.
Two Peptides, Two Completely Different Parents
Both Semax and Selank were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Both are synthetic heptapeptides with a C-terminal Pro-Gly-Pro tail bolted on during synthesis to slow enzymatic breakdown. That's where the similarity ends.
Semax (Met-Glu-His-Phe-Pro-Gly-Pro) borrows its first four residues from ACTH 4-10, the active fragment of adrenocorticotropic hormone. The clever part: by truncating the rest of the ACTH molecule, the designers stripped out adrenal cortisol stimulation while keeping the neurotropic activity.
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) borrows its first four residues from tuftsin, an endogenous immunomodulatory peptide that comes from the heavy chain of immunoglobulin G. Completely different lineage. Completely different downstream signaling.
Think of it like taking the engine from a sports car and the engine from a luxury sedan, then bolting the same transmission onto both. The shared tail stabilizes them identically against degradation. Everything else diverges.
What Each One Actually Does in the Brain
Semax: neurotrophic and dopaminergic. The primary signals are BDNF and NGF upregulation in the hippocampus and basal forebrain, downstream dopamine and serotonin modulation, and mild enkephalinase inhibition (which nudges endogenous opioid tone). The behavioral output is alertness, sharper attention under cognitive load, and a sense of "the fog lifted."
Selank: GABAergic and immunomodulatory. The primary signals are allosteric GABA modulation that produces anxiolysis without touching the benzodiazepine binding site, BDNF upregulation (yes, overlapping with Semax here), cytokine normalization including IL-6 effects, and the same enkephalinase inhibition. The behavioral output is reduced background anxiety, better emotional regulation, and calm without sedation.
The GABAergic-versus-dopaminergic split is the main event. It explains why two molecules that share a tail and a delivery route produce such opposite subjective experiences.
The Research: Real but Imperfect
Both peptides carry a meaningful research base. Neither carries the kind of large, randomized, placebo-controlled Western trial data that would satisfy a skeptical FDA reviewer.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Semax has its strongest evidence in ischemic stroke recovery. It sits on Russia's official list of essential medicines for that indication. Beyond stroke, there are smaller studies on cognitive enhancement in healthy adults under load and adjunct use in ADHD contexts. The stroke data is genuinely substantial by Russian clinical trial standards.
Selank has its strongest evidence in generalized anxiety disorder, where it is approved as a prescription anxiolytic in Russia. Head-to-head comparisons against medazepam (a benzodiazepine) exist. Smaller studies explore stress resilience and adjunct use during opioid or alcohol withdrawal.
The honest caveat: both research bases are predominantly Russian-origin, predominantly open-label in design, and have limited independent Western replication. That doesn't make them worthless. It does mean the evidence is directional rather than definitive for most of the use cases people care about.
When You'd Pick One Over the Other
This is simpler than most peptide comparisons.
If the goal is cognitive enhancement, attentional support, or recovery from brain fog and cognitive fatigue, Semax is the more mechanistically direct choice. Russian ADHD-adjunct research has used Semax, not Selank. Typical dosing runs morning and midday.
If the goal is anxiety reduction, stress resilience, or trouble falling asleep because your mind won't stop racing, Selank is the more direct match. It can be dosed morning, midday, or evening depending on what you're targeting.
If you want both (and plenty of people do), a combined protocol with Semax in the morning and Selank later in the day is what some prescribers use. No formal trial validates the combination as superior to either alone, so this remains a clinical judgment call.
Where this falls apart is when people try to substitute one for the other. Using Selank for focus support is like using a sedative to study. Using Semax for anxiety is, at best, irrelevant and, at worst, counterproductive. They're complementary, not interchangeable.
Practical Dosing and Tolerability
Dosing reference ranges differ, and the difference matters:
- Semax: 250 to 600 mcg per day, split across two or three intranasal administrations.
- Selank: 750 to 1,500 mcg per day, split across two or three intranasal administrations.
Selank doses are higher in raw microgram terms. That doesn't mean it's weaker; the peptides act on different systems with different potency profiles. Direct microgram-to-microgram comparison is meaningless.
Both peptides are well tolerated. The side effect profiles are mild and infrequent:
- Semax: occasional headache early on, transient overstimulation if dosed too late or too high, mild nasal irritation from the spray vehicle.
- Selank: occasional headache, rare mild drowsiness (usually transient), mild nasal irritation. Less likely than Semax to interfere with sleep.
Neither peptide shows a dependence or withdrawal signature in available literature. That's a meaningful differentiator from, say, benzodiazepines, which Selank has been compared against in Russian anxiety trials.
The Variant Forms (N-Acetyl, Amidate)
Both peptides have modified versions: N-Acetyl Semax, N-Acetyl Semax Amidate, N-Acetyl Selank, and N-Acetyl Selank Amidate. The modifications extend half-life relative to the base molecules without changing the per-dose microgram ranges. The boring truth is that these variants don't change what the peptide does; they change how long it does it per administration. If you're choosing between base and amidate, you're choosing duration of action, not mechanism.
My Honest Take
If I had to make one opinionated statement about these two peptides, it's this: Selank is underappreciated relative to Semax in the Western peptide community. Semax gets more search volume, more Reddit threads, more nootropic-stack mentions. But the Selank anxiety data, particularly the Russian GAD studies comparing it to benzodiazepines, represents some of the more interesting peptide research out there. An anxiolytic that modulates GABA allosterically without benzodiazepine-site binding, carries no dependence profile, and preserves cognitive function? That's a genuinely interesting pharmacological profile, and it deserves more attention than it gets.
Frequently Asked Questions
Are Semax and Selank the same peptide?
No. They are structurally distinct heptapeptides derived from different parent molecules (ACTH for Semax, tuftsin for Selank) with different mechanisms and different subjective profiles.
Can I take Semax and Selank together?
Some clinicians describe combined morning Semax and later-day Selank protocols. The combination is a prescriber decision and has not been formally validated against either peptide alone.
Which is better for ADHD?
Semax has the more direct mechanistic basis for attention support. Russian ADHD adjunct research has used Semax rather than Selank. Neither is FDA-approved for ADHD.
Which is better for sleep?
Neither is primarily a sleep peptide. Selank can support sleep when anxiety is the obstacle to sleep onset. DSIP is more directly positioned as a sleep peptide.
Do both come from Russia?
Both were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Both are approved as prescription medicines in Russia for specific indications.
Is one safer than the other?
Both carry favorable tolerability profiles in available literature. Neither shows dependence or withdrawal signals. Semax is slightly more likely to cause overstimulation if dosed late; Selank is slightly more likely to cause transient mild drowsiness. Neither difference is clinically significant for most users.
Do the N-Acetyl variants work differently?
They extend duration of action per dose but don't change the core mechanism. Same peptide, longer activity window.
Related Reading
- Semax Hub
- Selank Hub
- Semax Dosage Protocols
- Selank Dosage Protocols
- N-Acetyl Semax Amidate versus Semax
Compliance Footer
Neither Semax nor Selank is approved by the FDA for the prevention, mitigation, treatment, or cure of any disease. Compounded Semax and Selank are prepared by licensed compounding pharmacies for individual patients under a valid prescription from a licensed prescriber. Information on this page is educational and is not medical advice. Individual results vary.
---
Not FDA-approved. Compounded peptides are prepared by licensed 503A pharmacies for individual patients based on a prescriber's clinical judgment. FormBlends is not a medical practice. Individual results vary. Consult a licensed clinician before starting any peptide therapy.